Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss.
暂无分享,去创建一个
N. Perkins | S. Mumford | E. Schisterman | L. Sjaarda | Keewan Kim | K. Flannagan | R. Silver | J. Radoc
[1] M. Menke,et al. Selective Serotonin Reuptake Inhibitors and Fertility: Considerations for Couples Trying to Conceive , 2019, Harvard review of psychiatry.
[2] C. Coutifaris,et al. Major depression, antidepressant use, and male and female fertility. , 2018, Fertility and sterility.
[3] A. Butwick,et al. Prevalence of Depression Among Women of Reproductive Age in the United States. , 2018, Obstetrics and gynecology.
[4] Q. Gu,et al. Antidepressant Use Among Persons Aged 12 and Over:United States,2011-2014. , 2017, NCHS data brief.
[5] K. Rothman,et al. Depression, anxiety, and psychotropic medication use and fecundability. , 2016, American journal of obstetrics and gynecology.
[6] Marianne M. Casilla-Lennon,et al. The effect of antidepressants on fertility. , 2016, American journal of obstetrics and gynecology.
[7] Nisha D Almeida,et al. Risk of Miscarriage in Women Receiving Antidepressants in Early Pregnancy, Correcting for Induced Abortions , 2016, Epidemiology.
[8] Enrique F Schisterman,et al. Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss. , 2016, Human reproduction.
[9] S. Gilboa,et al. Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013. , 2016, MMWR. Morbidity and mortality weekly report.
[10] C. Gnoth,et al. Development of the first urinary reproductive hormone ranges referenced to independently determined ovulation day , 2015, Clinical chemistry and laboratory medicine.
[11] E. Garne,et al. Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population‐based study in six European regions , 2015, BJOG : an international journal of obstetrics and gynaecology.
[12] A. Hansen,et al. Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases. , 2015, Paediatric and perinatal epidemiology.
[13] B. Stricker,et al. Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study , 2015, European Journal of Clinical Pharmacology.
[14] H. Poulsen,et al. Exposure to Selective Serotonin Reuptake Inhibitors in Early Pregnancy and the Risk of Miscarriage , 2014, Obstetrics and gynecology.
[15] Enrique F Schisterman,et al. A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics. , 2013, Paediatric and perinatal epidemiology.
[16] J. Olsen,et al. Prenatal Antidepressant Exposure and Risk of Spontaneous Abortion – A Population-Based Study , 2013, PloS one.
[17] J. West,et al. Live and Non-Live Pregnancy Outcomes among Women with Depression and Anxiety: A Population-Based Study , 2012, PloS one.
[18] M. Bixo,et al. Allopregnanolone, a GABAA receptor agonist, decreases gonadotropin levels in women. A preliminary study , 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[19] A. Higgins,et al. Antidepressant-associated sexual dysfunction: impact, effects, and treatment. , 2010, Drug, healthcare and patient safety.
[20] A. Bérard,et al. Use of antidepressants during pregnancy and the risk of spontaneous abortion , 2010, Canadian Medical Association Journal.
[21] T. Einarson,et al. Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. , 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[22] D. Stewart,et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. , 2009, Obstetrics and gynecology.
[23] J. Skurnick,et al. Characteristics of the urinary luteinizing hormone surge in young ovulatory women. , 2007, Fertility and sterility.
[24] S. Moenter,et al. Neurosteroids alter gamma-aminobutyric acid postsynaptic currents in gonadotropin-releasing hormone neurons: a possible mechanism for direct steroidal control. , 2003, Endocrinology.
[25] P. Marken,et al. Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features. , 2000, Primary care companion to the Journal of clinical psychiatry.
[26] C. Weinberg,et al. Time of implantation of the conceptus and loss of pregnancy. , 1999, The New England journal of medicine.
[27] F. Petraglia,et al. The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acidA receptor. , 1998, The Journal of endocrinology.
[28] K. Jones,et al. Birth outcomes in pregnant women taking fluoxetine. , 1996, New England Journal of Medicine.
[29] G. Koren,et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac) , 1993, JAMA.